EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access · CC BY 4.0

Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy Adults

Sanjay M Mallya, Paul Kostenuik, René Hopfinger, Mansur Ahmad, James Mah, Shawneen Gonzalez, Donna L Faletto, Elisabeth Lee, Beta Bowen, Reva Mccaskill, Mitchell F Brin

Aesthetic Surgery Journal · 17.11.2026 · 46 (12) · NP169-NP183

DOI: 10.1093/asj/sjag080 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 24.04.2026. Verfasst von Sanjay M Mallya und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Masseter Muscle, Mandible, Neuromuscular Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergan Aesthetics, an AbbVie company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Botulinum neurotoxins (eg, onabotulinumtoxinA) are used off-label to treat masseter muscle prominence (MMP), a benign enlargement of the masseter muscles that may be aesthetically undesirable. Limited evidence suggests that botulinum neurotoxin injections into masticatory muscles may adversely affect mandibular morphology, but this has not been rigorously investigated in context of MMP.

Objectives

To evaluate whether mandibular morphology changes occur in individuals with MMP following bilateral masseter treatment with onabotulinumtoxinA.

Methods

In a 12-month, double-blind, placebo-controlled, Phase 2 study, 187 healthy adults with bilateral MMP received 1 or 2 onabotulinumtoxinA treatments (24, 48, 72, or 96 U) or placebo. Multidetector computed tomography (MDCT) scans (baseline, days 90 and 360) were evaluated using quantitative and qualitative mandibular morphology indicators. Adverse events (AEs) were monitored throughout.

Results

Quantitative assessments of bigonial width, cortical thickness, mandibular flare, and gonial angles found no differences between onabotulinumtoxinA (n = 150) and placebo (n = 37). Most participants (94%) showed no qualitative changes to mandibular condylar head (shape, position, cortical surface, and cortical thickness), glenoid fossa, or articular eminence (appearance, cortical surface). No clinically significant changes were identified after repeated qualitative assessments in 12 participants with findings suggestive of postbaseline osteopathic change. The most reported treatment-related AE, mastication disorder (6.0%), was consistent with prior reports following onabotulinumtoxinA masseter treatment for MMP.

Conclusions

Quantitative and qualitative MDCT evaluations showed no detectable differences in predefined mandibular morphometric measures vs placebo after 1 or 2 onabotulinumtoxinA treatments for MMP over 1 year. Safety events were localized and consistent with drug mechanism. Late-emerging effects beyond 12 months cannot be excluded. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AMasseter MuscleMandibleNeuromuscular AgentsMultidetector Computed TomographyHumansFemaleAdultDouble-Blind MethodMaleYoung AdultMiddle AgedLongitudinal StudiesInjections, IntramuscularHypertrophyTreatment OutcomeTime FactorsAdolescentHealthy Volunteers

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin ANeuromuscular Agents

Förderung

  • Allergan Aesthetics, an AbbVie company

Zitieren

APA

Mallya, S. M., Kostenuik, P., Hopfinger, R., Ahmad, M., Mah, J., Gonzalez, S., Faletto, D. L., Lee, E., Bowen, B., Mccaskill, R., & Brin, M. F. (2026). Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy Adults. Aesthetic Surgery Journal, 46(12), NP169-NP183. https://doi.org/10.1093/asj/sjag080

Vancouver

Mallya SM, Kostenuik P, Hopfinger R, Ahmad M, Mah J, Gonzalez S, et al. Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy Adults. Aesthetic Surgery Journal. 2026;46(12):NP169-NP183. doi:10.1093/asj/sjag080

BibTeX
@article{Mallya2026,
  author = {Mallya, Sanjay M and Kostenuik, Paul and Hopfinger, René and Ahmad, Mansur and Mah, James and Gonzalez, Shawneen and Faletto, Donna L and Lee, Elisabeth and Bowen, Beta and Mccaskill, Reva and Brin, Mitchell F},
  title = {Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy Adults},
  journal = {Aesthetic Surgery Journal},
  year = {2026},
  volume = {46},
  number = {12},
  pages = {NP169--NP183},
  doi = {10.1093/asj/sjag080}
}
Kostenlos starten →